Cardioneuroablation: Which Patients, Which Endpoints, What Evidence?

Cardioneuroablation is moving rapidly from experimental concept toward clinical practice, but the field still lacks consensus on who should be treated, how success should be measured, and what evidence is sufficient for adoption. This session brings together leading experts to debate patient selection, procedural targets, endpoint definition, durability, safety, and trial design. The discussion will separate established practice from unresolved questions and define what the field must prove next.